You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tipifarnib

Showing 51 - 75 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Childhood High-grade Cerebral Astrocytoma, Childhood Oligodendroglioma, Recurrent Childhood Brain Stem Glioma Trial in Arcadia

Completed
  • Childhood High-grade Cerebral Astrocytoma
  • +7 more
  • tipifarnib
  • Arcadia, California
    Children's Oncology Group
Oct 7, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in San Francisco, Tampa (chemo, tipifarnib)

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • San Francisco, California
  • +1 more
Dec 3, 2013

Breast Cancer Trial run by the NCI (tamoxifen citrate, tipifarnib)

Completed
  • Breast Cancer
  • tamoxifen citrate
  • tipifarnib
  • Bethesda, Maryland
  • +1 more
Jun 18, 2013

Recurrent Melanoma, Stage IV Melanoma Trial in Chicago (tipifarnib, laboratory biomarker analysis)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • tipifarnib
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jun 4, 2013

Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Rochester (tipifarnib, laboratory biomarker

Completed
  • Essential Thrombocythemia
  • +2 more
  • tipifarnib
  • laboratory biomarker analysis
  • Rochester, Minnesota
    Mayo Clinic
Jun 3, 2013

Stage IIIB NSCLC, Stage IV NSCLC Trial in Rochester (tipifarnib, cisplatin, gemcitabine HCl)

Completed
  • Stage IIIB Non-small Cell Lung Cancer
  • Stage IV Non-small Cell Lung Cancer
  • tipifarnib
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Jun 3, 2013

Inflammatory Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Bronx (drug, biological, procedure, other)

Completed
  • Inflammatory Breast Cancer
  • +4 more
  • doxorubicin hydrochloride
  • +5 more
  • Bronx, New York
    Albert Einstein College of Medicine
Jun 5, 2013

Leukemia Trial in Columbus (cytarabine, daunorubicin HCl, etoposide)

Terminated
  • Leukemia
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
May 1, 2013

Prostate Cancer Trial in Cleveland, Philadelphia (chemo, tipifarnib)

Completed
  • Prostate Cancer
  • Cleveland, Ohio
  • +1 more
Jul 10, 2013

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in Baltimore (tipifarnib, radiation therapy)

Completed
  • Adult Giant Cell Glioblastoma
  • +2 more
  • tipifarnib
  • radiation therapy
  • Baltimore, Maryland
    New Approaches to Brain Tumor Therapy Consortium
Apr 8, 2013

Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Boston (tipifarnib, capecitabine)

Completed
  • Recurrent Breast Cancer
  • Stage IV Breast Cancer
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Feb 26, 2013

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

Completed
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +20 more
  • tipifarnib
  • laboratory biomarker analysis
  • Baltimore, Maryland
    Johns Hopkins University
Mar 22, 2013

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago (tipifarnib)

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • tipifarnib
  • Chicago, Illinois
    University of Chicago Cancer Research Center
Feb 8, 2013

Leukemia, MDS Trial in United Kingdom (biological, drug, genetic, other, procedure)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • alemtuzumab
  • +18 more
  • Basingstoke, England, United Kingdom
  • +95 more
Aug 23, 2013

Breast Cancer Trial in Worldwide (ZARNESTRA, tipifarnib, R115777)

Completed
  • Breast Cancer
  • ZARNESTRA, tipifarnib, R115777
  • Miami, Florida
  • +24 more
Jan 31, 2013

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • tipifarnib
  • San Antonio, Texas
    Southwest Oncology Group
Jan 14, 2013

Multiple Myeloma Trial in Tampa (PS-341, R11577)

Terminated
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Nov 21, 2013

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • Baltimore, Maryland
    Johns Hopkins University
Jan 8, 2013

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Erythroid Leukemia (M6),

Completed
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +18 more
  • tipifarnib
  • +2 more
  • Duarte, California
    City of Hope
Feb 1, 2013

Cancer Trial in Fort Sam Houston, San Antonio (trastuzumab, tipifarnib)

Completed
  • Cancer
  • trastuzumab
  • tipifarnib
  • Fort Sam Houston, Texas
  • +1 more
Feb 8, 2013

Pancreatic Cancer Trial in Philadelphia, Houston (tipifarnib)

Completed
  • Pancreatic Cancer
  • tipifarnib
  • Philadelphia, Pennsylvania
  • +1 more
Feb 8, 2013

Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +8 more
  • tipifarnib
  • Baltimore, Maryland
    Johns Hopkins University
Jan 8, 2013

Juvenile Myelomonocytic Leukemia Trial in Arcadia (drug, radiation, biological, procedure, other)

Completed
  • Juvenile Myelomonocytic Leukemia
  • tipifarnib
  • +10 more
  • Arcadia, California
    Children's Oncology Group
Apr 10, 2013

Lung Cancer Trial in New York (tipifarnib)

Completed
  • Lung Cancer
  • tipifarnib
  • New York, New York
    Kaplan Cancer Center
Nov 8, 2012

Solid Tumor Trial in New York (tipifarnib, topotecan HCl)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • tipifarnib
  • topotecan hydrochloride
  • New York, New York
    NYU Cancer Institute at New York University Medical Center
Nov 8, 2012